Newsroom

AUSTIN, Texas--(BUSINESS WIRE)--Long before “sustainability” became a corporate buzzword, Seventh Generation was building a business around the idea that companies should serve people and the planet, not just profit. In Built for a Better World: How Seventh Generation Pioneered a Movement That Changed the Purpose of Business (March 24th, 2026; Fast Company Press; $19.95), Seventh Generation cofounder Jeffrey Hollender shares the inside story of helping pioneer the sustainable business movement,...

DULUTH, Minn. & KNOXVILLE, Tenn.--(BUSINESS WIRE)--Cirrus (Cirrus Aircraft Ltd.) launched its Mission Ready Simulator Sessions, a comprehensive, year-long simulator training program developed specifically for Cirrus SR20 and Cirrus SR22 pilots. The complimentary program is now live and available at participating Cirrus Training Centers in the U.S. Mission Ready Simulator delivers 24 structured, mission-based simulator sessions released twice per month, giving SR Series pilots a continuous, scen...

NEW YORK--(BUSINESS WIRE)--Acker set a new world record in fine wine this past weekend....

ESPOO, Finnland--(BUSINESS WIRE)--IQM Finland Oy, ein weltweit führender Anbieter von Full-Stack-Quantencomputern auf Basis von Supraleitung („IQM“, „IQM Quantum Computers“ oder das „Unternehmen“), gab heute bekannt, dass es sich ein Finanzierungspaket in Höhe von 50 Millionen Euro von Fonds und Konten gesichert hat, die von BlackRock verwaltet werden. Diese Finanzierung wird die Beschleunigung der Technologie-Roadmap von IQM unterstützen, Forschung und Entwicklung vorantreiben, den Eintritt in...

ESPOO, Finlandia--(BUSINESS WIRE)--IQM Finland Oy, líder mundial en ordenadores cuánticos superconductores de pila completa («IQM», «IQM Quantum Computers» o la «Compañía»), acaba de anunciar que ha obtenido un paquete de financiación de 50 millones de euros procedente de fondos y cuentas gestionados por BlackRock. Esta línea de financiación contribuirá a acelerar la hoja de ruta tecnológica de IQM, impulsará proyectos de I+D, facilitará la entrada en nuevos mercados y reforzará el liderazgo de...

ESPOO, Finlande--(BUSINESS WIRE)--IQM Finland Oy, leader mondial des ordinateurs quantiques supraconducteurs full-stack (« IQM », « IQM Quantum Computers » ou la « société »), a annoncé aujourd’hui avoir obtenu un financement de 50 millions d’euros provenant de fonds et de comptes gérés par BlackRock. Ce financement contribuera à accélérer la feuille de route technologique d’IQM, à stimuler la R&D, à soutenir la pénétration de nouveaux marchés et à consolider le leadership d’IQM dans le dom...

ESPOO, Finlandia--(BUSINESS WIRE)--IQM Finland Oy, leader globale nell'ambito di computer quantistici superconduttori full-stack ("IQM", "IQM Quantum Computers" o l'"Azienda"), ha annunciato oggi di aver ottenuto un pacchetto di finanziamenti di 50 milioni di euro dai fondi e dagli account gestiti da BlackRock. Questo strumento supporterà l'accelerazione della roadmap tecnologica di IQM, promuoverà le attività di R&S, sosterrà l'accesso a ulteriori mercati e rafforzerà la leadership di IQM...

ESPOO, Finland--(BUSINESS WIRE)--IQM Finland Oy, wereldleider in full-stack supergeleidende kwantumcomputers (“IQM”, “IQM Quantum Computers” of het “Bedrijf”), maakte vandaag bekend dat het een financieringspakket van €50 miljoen heeft verzekerd uit fondsen en accounts beheerd door BlackRock. Deze faciliteit zal versnelling van IQM’s technologieroadmap aanmoedigen, R&D versterken, het aantreden op extra markten ondersteunen en IQM’s leiderschap in kwantumcomputing bevorderen. Deze bekendmak...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of ImmunityBio, Inc. (“ImmunityBio” or the “Company”) (NASDAQ: IBRX) investors concerning the Company’s possible violations of the federal securities laws.IF YOU ARE AN INVESTOR WHO LOST MONEY ON IMMUNITYBIO, INC. (IBRX), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS.What Happened?On Ma...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new clinical and real-world data from its cardiovascular (CV) portfolio presented at the American College of Cardiology’s Annual Scientific Session and Expo (ACC.26), reinforcing the potential of RNAi to deliver fundamentally differentiated, effective, and durable impact for patients living with cardiovascular disease (CVD). New data continue to support the use...